Arinna Lifesciences
Tracked across 4 events · 37 articles · First seen Apr 14, 2026 · Last active Aug 19, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Arinna Lifesciences was acquired by Rubicon Research for approximately INR 175.92 crore for an 85% stake. Its founder, Vivek Seth, will retain a 15% stake and continue as Managing Director, providing continuity and leveraging its existing network for Rubicon Research.
Apr 14, 2026 · 8 articles
Business
HELM AG, a global chemical company headquartered in Germany, and Parijat Industries (India) Limited, an India-based agrochemical company, announced a multi-faceted strategic collaboration. The partnership spans digital commerce, branded crop protection products, technical manufacturing, and…
Impact: Arinna Lifesciences, a subsidiary of Parijat, will secure exclusive rights to use HELM branding in India, supporting the launch of new product lines.
Aug 17, 2026 · 6 articles
Business
Symbiotec Pharmalab, an Indore-based pharmaceutical and biotechnology company, is launching its initial public offering (IPO) on August 24, 2026, with a price band of Rs 938-988 per share. The IPO aims to raise Rs 1,757…
Impact: As a listed peer, Arinna Lifesciences may be compared but is not directly impacted.
Aug 19, 2026 · 8 articles
Business
Molbio Diagnostics Ltd, a Goa-based point-of-care molecular diagnostics company, has fixed a price band of Rs 768-807 per share for its initial public offering (IPO). The issue, valued at approximately Rs 930-940 crore, comprises a…
Impact: Arinna Lifesciences has a collaboration with Molbio for cancer screening, but is not directly involved in the IPO.
Aug 05, 2026 · 15 articles
ERGEN INTELLIGENCE
Track Arinna Lifesciences live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard